Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP -Deleted KRAS -Mutant Pancreatic Cancer

平台已收录预计检索 <10 秒

查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。

文献信息

题目: Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP -Deleted KRAS -Mutant Pancreatic Cancer
作者: Kristina Drizyte-Miller, Lars D. Engstrom, Jeffrey A. Klomp, Clint A. Stalnecker, Addison G. Stamey, Khalilah E. Taylor, Mallory K. Roach, Ryan Robb, Laura M. Waters, Andrew Calinisan, Seamus Degan, Wen-Hsuan Chang, Xousaen M. Helu, David Nguyen, Elisa Baldelli, Mariaelena Pierobon, Emanuel F. Petricoin, David M. Briere, Jill Hallin, James G. Christensen, Kirsten L. Bryant, Adrienne D. Cox, Peter Olson, Channing J. Der
发表年份: 2025
期刊 / 来源: Cancer Research
出版社: American Association for Cancer Research
DOI: 10.1158/0008-5472.can-25-1507
文献类型: 学术文献
平台记录更新: 2026-09-01 15:09:17

本页由 Scihuhuan.com 学术互换提供文献检索、引用与获取指引；论文版权和出版身份归原出版方。